Stem cell transplantation therapy for diabetic foot ulcer: a narrative review

[1] Noor S, Zubair M, Ahmad J. Diabetic foot ulcer—a review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr. 2015; 9:192–9. NoorS ZubairM AhmadJ Diabetic foot ulcer—a review on pathophysiology, classification and microbial etiology Diabetes Metab Syndr 2015 9 192 9 10.1016/j.dsx.2015.04.00725982677 Search in Google Scholar

[2] Arshad M, Arshad S, Arshad S, Abbas H. The quality of life in patients with diabetic foot ulcers. J Diab Metab. 2020; 11:e101. doi: 10.35248/2155-6156.20.11.e101. ArshadM ArshadS ArshadS AbbasH The quality of life in patients with diabetic foot ulcers J Diab Metab 2020 11 e101 10.35248/2155-6156.20.11.e101 Open DOISearch in Google Scholar

[3] Haghdoost A, Rezazadeh Kermani M, Sadghirad B, Baradaran H. Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis. Eastern Mediterr Health J. 2009: 15:591–9. HaghdoostA Rezazadeh KermaniM SadghiradB BaradaranH Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis Eastern Mediterr Health J 2009 15 591 9 10.26719/2009.15.3.591 Search in Google Scholar

[4] Shafiee S, Raz A, Adibi N, Mansouri M, Annabestani Z, Mirzaeezadeh Z, et al. Assessment of the relationship between -1562C>T allele of MMP9 gene promoter with diabetic foot ulcer in type 2 diabetic patients referred to the clinic of diabetes & metabolic diseases. Iranian J Diabetes Metabol. 2018; 17:49–56. [in Persian; English title and abstract] ShafieeS RazA AdibiN MansouriM AnnabestaniZ MirzaeezadehZ Assessment of the relationship between -1562C>T allele of MMP9 gene promoter with diabetic foot ulcer in type 2 diabetic patients referred to the clinic of diabetes & metabolic diseases Iranian J Diabetes Metabol 2018 17 49 56 [in Persian; English title and abstract] Search in Google Scholar

[5] Weledji EP, Fokam P. Treatment of the diabetic foot – to amputate or not? BMC Surg. 2014; 14:83. doi: 10.1186/1471-2482-14-83 WeledjiEP FokamP Treatment of the diabetic foot – to amputate or not? BMC Surg 2014 14 83 10.1186/1471-2482-14-83421899325344293 Open DOISearch in Google Scholar

[6] Cao Y, Gang X, Sun C, Wang G. Mesenchymal stem cells improve healing of diabetic foot ulcer. J Diabetes Res. 2017; 2017:9328347. doi: 10.1155/2017/9328347 CaoY GangX SunC WangG Mesenchymal stem cells improve healing of diabetic foot ulcer J Diabetes Res 2017 2017 9328347. 10.1155/2017/9328347536620128386568 Open DOISearch in Google Scholar

[7] Guo J, Dardik A, Fang K, Huang R, Gu Y. Meta-analysis on the treatment of diabetic foot ulcers with autologous stem cells. Stem Cell Res Ther. 2017; 8:228. doi: 10.1186/s13287-017-0683-2 GuoJ DardikA FangK HuangR GuY Meta-analysis on the treatment of diabetic foot ulcers with autologous stem cells Stem Cell Res Ther 2017 8 228 10.1186/s13287-017-0683-2564417129037219 Open DOISearch in Google Scholar

[8] Shu X, Shu S, Tang S, Yang L, Liu D, Li K, et al. Efficiency of stem cell based therapy in the treatment of diabetic foot ulcer: a meta-analysis. Endocr J. 2018; 65:403–13. ShuX ShuS TangS YangL LiuD LiK Efficiency of stem cell based therapy in the treatment of diabetic foot ulcer: a meta-analysis Endocr J 2018 65 403 13 10.1507/endocrj.EJ17-042429353870 Search in Google Scholar

[9] Heublein H, Bader A, Giri S. Preclinical and clinical evidence for stem cell therapies as treatment for diabetic wounds. Drug Discov Today. 2015; 20:703–17. HeubleinH BaderA GiriS Preclinical and clinical evidence for stem cell therapies as treatment for diabetic wounds Drug Discov Today 2015 20 703 17 10.1016/j.drudis.2015.01.00525603421 Search in Google Scholar

[10] Meamar R, Nasr-Esfahani MH, Mousavi SA, Basiri K. Stem cell therapy in amyotrophic lateral sclerosis. J Clin Neurosci. 2013; 20:1659–63. MeamarR Nasr-EsfahaniMH MousaviSA BasiriK Stem cell therapy in amyotrophic lateral sclerosis J Clin Neurosci 2013 20 1659 63 10.1016/j.jocn.2013.04.02424148693 Search in Google Scholar

[11] Blumberg SN, Berger A, Hwang L, Pastar I, Warren SM, Chen W. The role of stem cells in the treatment of diabetic foot ulcers. Diabetes Res Clin Pract. 2012; 96:1–9. BlumbergSN BergerA HwangL PastarI WarrenSM ChenW The role of stem cells in the treatment of diabetic foot ulcers Diabetes Res Clin Pract 2012 96 1 9 10.1016/j.diabres.2011.10.03222142631 Search in Google Scholar

[12] Ariyanti AD, Zhang J, Marcelina O, Nugrahaningrum DA, Wang G, Kasim V, Wu S. Salidroside-pretreated mesenchymal stem cells enhance diabetic wound healing by promoting paracrine function and survival of mesenchymal stem cells under hyperglycemia. Stem Cells Transl Med. 2019; 8:404–14. AriyantiAD ZhangJ MarcelinaO NugrahaningrumDA WangG KasimV WuS Salidroside-pretreated mesenchymal stem cells enhance diabetic wound healing by promoting paracrine function and survival of mesenchymal stem cells under hyperglycemia Stem Cells Transl Med 2019 8 404 14 10.1002/sctm.18-0143643160730624028 Search in Google Scholar

[13] Holm JS, Toyserkani NM, Sorensen JA. Adipose-derived stem cells for treatment of chronic ulcers: current status. Stem Cell Res Ther. 2018; 9:142. doi: 10.1186/s13287-018-0887-0 HolmJS ToyserkaniNM SorensenJA Adipose-derived stem cells for treatment of chronic ulcers: current status Stem Cell Res Ther 2018 9 142 10.1186/s13287-018-0887-0595237029764508 Open DOISearch in Google Scholar

[14] Qin HL, Zhu XH, Zhang B, Zhou L, Wang WY. Clinical evaluation of human umbilical cord mesenchymal stem cell transplantation after angioplasty for diabetic foot. Exp Clin Endocrinol Diabetes. 2016; 124:497–503. QinHL ZhuXH ZhangB ZhouL WangWY Clinical evaluation of human umbilical cord mesenchymal stem cell transplantation after angioplasty for diabetic foot Exp Clin Endocrinol Diabetes 2016 124 497 503 10.1055/s-0042-10368427219884 Search in Google Scholar

[15] Davey GC, Patil SB, O’Loughlin A, O’Brien T. Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus. Front Endocrinol (Lausanne). 2014; 5:86. doi: 10.3389/fendo.2014.00086 DaveyGC PatilSB O’LoughlinA O’BrienT Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus Front Endocrinol (Lausanne) 2014 5 86 10.3389/fendo.2014.00086404767924936198 Open DOISearch in Google Scholar

[16] Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, Lemischka IR. A stem cell molecular signature. Science. 2002; 298(5593):601–4. IvanovaNB DimosJT SchanielC HackneyJA MooreKA LemischkaIR A stem cell molecular signature Science 2002 298 5593 601 4 10.1126/science.107382312228721 Search in Google Scholar

[17] Arwert EN, Hoste E, Watt FM. Epithelial stem cells, wound healing and cancer. Nature Rev Cancer. 2012; 12:170–80. ArwertEN HosteE WattFM Epithelial stem cells, wound healing and cancer Nature Rev Cancer 2012 12 170 80 10.1038/nrc321722362215 Search in Google Scholar

[18] Li Z, Hu X, Zhong JF. Mesenchymal stem cells: characteristics, function, and application. Stem Cells Int. 2019; 2019:8106818. doi: 10.1155/2019/8106818 LiZ HuX ZhongJF Mesenchymal stem cells: characteristics, function, and application Stem Cells Int 2019 2019 8106818 10.1155/2019/8106818643137230956675 Open DOISearch in Google Scholar

[19] Banijamali RS, Soleimanjahi H, Soudi S, Karimi H, Abdoli A, Khorrami SMS, Zandi K. Kinetics of oncolytic reovirus T3D replication and growth pattern in mesenchymal stem cells. Cell J. 2020; 22:283–92. BanijamaliRS SoleimanjahiH SoudiS KarimiH AbdoliA KhorramiSMS ZandiK Kinetics of oncolytic reovirus T3D replication and growth pattern in mesenchymal stem cells Cell J 2020 22 283 92 Search in Google Scholar

[20] Dash NR, Dash SN, Routray P, Mohapatra S, Mohapatra PC. Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Res. 2009; 12:359–66. DashNR DashSN RoutrayP MohapatraS MohapatraPC Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells Rejuvenation Res 2009 12 359 66 10.1089/rej.2009.087219929258 Search in Google Scholar

[21] Patel AN, Bartlett CE, Ichim TE. Mesenchymal Stem Cells. In: Perin EC, Miller LW, Taylor D, Willerson JT, editors. Stem cell and gene therapy for cardiovascular disease. Amsterdam: Elsevier Academic Press; 2016, p. 139–50. PatelAN BartlettCE IchimTE Mesenchymal Stem Cells In: PerinEC MillerLW TaylorD WillersonJT editors. Stem cell and gene therapy for cardiovascular disease Amsterdam Elsevier Academic Press 2016 139 50 10.1016/B978-0-12-801888-0.00011-4 Search in Google Scholar

[22] Kong P, Xie X, Li F, Liu Y, Lu Y. Placenta mesenchymal stem cell accelerates wound healing by enhancing angiogenesis in diabetic Goto-Kakizaki (GK) rats. Biochem Biophys Res Commun. 2013; 438:410–9. KongP XieX LiF LiuY LuY Placenta mesenchymal stem cell accelerates wound healing by enhancing angiogenesis in diabetic Goto-Kakizaki (GK) rats Biochem Biophys Res Commun 2013 438 410 9 10.1016/j.bbrc.2013.07.08823899518 Search in Google Scholar

[23] Wang Y, Dan Q, Wang Q, Zhou N, Jin X, Hou Z, et al. [Human umbilic mesenchymal stromal cells repairs diabetic foot in rats associated with VEGF expressional change]. Sichuan Da Xue Xue Bao Yi Xue Ban [J Sichuan Univ. Med Sci Edition]. 2014; 45:29–33. [article in Chinese, English Abstract] WangY DanQ WangQ ZhouN JinX HouZ [Human umbilic mesenchymal stromal cells repairs diabetic foot in rats associated with VEGF expressional change] Sichuan Da Xue Xue Bao Yi Xue Ban [J Sichuan Univ. Med Sci Edition] 2014 45 29 33 [article in Chinese, English Abstract] Search in Google Scholar

[24] Son W-S, Park HJ, Lee C-J, Kim S-N, Song SU, Park G, Lee Y-W. Supercritical drying of vascular endothelial growth factor in mesenchymal stem cells culture fluids. J Supercritical Fluids. 2020; 157:104710. doi: 10.1016/j.supflu.2019.104710 SonW-S ParkHJ LeeC-J KimS-N SongSU ParkG LeeY-W Supercritical drying of vascular endothelial growth factor in mesenchymal stem cells culture fluids J Supercritical Fluids 2020 157 104710. 10.1016/j.supflu.2019.104710 Open DOISearch in Google Scholar

[25] Shen L, Zeng W, Wu Y-X, Hou C-L, Chen W, Yang M-C, et al. Neurotrophin-3 accelerates wound healing in diabetic mice by promoting a paracrine response in mesenchymal stem cells. Cell Transplant. 2013; 22:1011–21. ShenL ZengW WuY-X HouC-L ChenW YangM-C Neurotrophin-3 accelerates wound healing in diabetic mice by promoting a paracrine response in mesenchymal stem cells Cell Transplant 2013 22 1011 21 10.3727/096368912X657495 Search in Google Scholar

[26] Tsyb A, Petrov V, Konoplyannikov A, Saypina E, Lepechina L, Kalsina SS, et al. In vitro inhibitory effect of mesenchymal stem cells on zymosan-induced production of reactive oxygen species. Bull Exp Biol Med. 2008; 146:158–64. TsybA PetrovV KonoplyannikovA SaypinaE LepechinaL KalsinaSS In vitro inhibitory effect of mesenchymal stem cells on zymosan-induced production of reactive oxygen species Bull Exp Biol Med 2008 146 158 64 10.1007/s10517-008-0238-8 Search in Google Scholar

[27] Pan G, Mu Y, Hou L, Liu J. Examining the therapeutic potential of various stem cell sources for differentiation into insulin-producing cells to treat diabetes. Ann Endocrinol (Paris). 2019; 80:47–53. PanG MuY HouL LiuJ Examining the therapeutic potential of various stem cell sources for differentiation into insulin-producing cells to treat diabetes Ann Endocrinol (Paris) 2019 80 47 53 10.1016/j.ando.2018.06.1084 Search in Google Scholar

[28] Wan J, Xia L, Liang W, Liu Y, Cai Q. Transplantation of bone marrow-derived mesenchymal stem cells promotes delayed wound healing in diabetic rats. J Diabetes Res. 2013; 2013:647107. doi: 10.1155/2013/647107 WanJ XiaL LiangW LiuY CaiQ Transplantation of bone marrow-derived mesenchymal stem cells promotes delayed wound healing in diabetic rats J Diabetes Res 2013 2013 647107. 10.1155/2013/647107 Open DOISearch in Google Scholar

[29] Wang L, Wang F, Zhao L, Yang W, Wan X, Yue C, Mo Z. Mesenchymal stem cells coated by the extracellular matrix promote wound healing in diabetic rats. Stem Cells Int. 2019; 2019:9564869. doi: 10.1155/2019/9564869. [Erratum: doi: 10.1155/2019/9581478] WangL WangF ZhaoL YangW WanX YueC MoZ Mesenchymal stem cells coated by the extracellular matrix promote wound healing in diabetic rats Stem Cells Int 2019 2019 9564869. 10.1155/2019/9564869 [Erratum: doi: 10.1155/2019/9581478] Open DOISearch in Google Scholar

[30] Debin L, Youzhao J, Ziwen L, Xiaoyan L, Zhonghui Z, Bing C. Autologous transplantation of bone marrow mesenchymal stem cells on diabetic patients with lower limb ischemia. J Med Colleges PLA. 2008; 23:106–15. DebinL YouzhaoJ ZiwenL XiaoyanL ZhonghuiZ BingC Autologous transplantation of bone marrow mesenchymal stem cells on diabetic patients with lower limb ischemia J Med Colleges PLA 2008 23 106 15 10.1016/S1000-1948(08)60031-3 Search in Google Scholar

[31] Jain P, Perakath B, Ranjan Jesudason M, Nayak S. The effect of autologous bone marrow-derived cells on healing chronic lower extremity wounds: results of a randomized controlled study. Ostomy Wound Manage. 2011; 57:38–34. JainP PerakathB Ranjan JesudasonM NayakS The effect of autologous bone marrow-derived cells on healing chronic lower extremity wounds: results of a randomized controlled study Ostomy Wound Manage 2011 57 38 34 Search in Google Scholar

[32] Liu Z, Yu D, Xu J, Li X, Wang X, He Z, Zhao T. Human umbilical cord mesenchymal stem cells improve irradiation-induced skin ulcers healing of rat models. Biomed Pharmacother. 2018; 101:729–36. LiuZ YuD XuJ LiX WangX HeZ ZhaoT Human umbilical cord mesenchymal stem cells improve irradiation-induced skin ulcers healing of rat models Biomed Pharmacother 2018 101 729 36 10.1016/j.biopha.2018.02.09329524881 Search in Google Scholar

[33] Kirana S, Stratmann B, Prante C, Prohaska W, Koerperich H, Lammers D, et al. Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients. Int J Clin Pract. 2012; 66:384–93. KiranaS StratmannB PranteC ProhaskaW KoerperichH LammersD Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients Int J Clin Pract 2012 66 384 93 10.1111/j.1742-1241.2011.02886.x22284892 Search in Google Scholar

[34] Lu D, Chen B, Liang Z, Deng W, Jiang Y, Li S, et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract. 2011; 92:26–36. LuD ChenB LiangZ DengW JiangY LiS Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial Diabetes Res Clin Pract 2011 92 26 36 10.1016/j.diabres.2010.12.01021216483 Search in Google Scholar

[35] Vojtaššák J, Danišovič L, Kubeš M, Bakoš D, Jarabek L, Uličná M, Blaško M. Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuroendocrinol Lett. 2006; 27(Suppl 2):134–7. VojtaššákJ DanišovičL KubešM BakošD JarabekL UličnáM BlaškoM Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot Neuroendocrinol Lett 2006 27 Suppl 2 134 7 Search in Google Scholar

[36] Wu Q, Lei X, Chen L, Zheng Y, Huang H, Qian C, Liang Z. Autologous platelet-rich gel combined with in vitro amplification of bone marrow mesenchymal stem cell transplantation to treat the diabetic foot ulcer: a case report. Ann Transl Med. 2018; 6:307. doi: 10.21037/atm.2018.07.12 WuQ LeiX ChenL ZhengY HuangH QianC LiangZ Autologous platelet-rich gel combined with in vitro amplification of bone marrow mesenchymal stem cell transplantation to treat the diabetic foot ulcer: a case report Ann Transl Med 2018 6 307 10.21037/atm.2018.07.12612320630211195 Open DOISearch in Google Scholar

[37] Li X-Y, Zheng Z-H, Li X-Y, Guo J, Zhang Y, Li H, et al. Treatment of foot disease in patients with type 2 diabetes mellitus using human umbilical cord blood mesenchymal stem cells: response and correction of immunological anomalies. Curr Pharm Des. 2013; 19:4893–9. LiX-Y ZhengZ-H LiX-Y GuoJ ZhangY LiH Treatment of foot disease in patients with type 2 diabetes mellitus using human umbilical cord blood mesenchymal stem cells: response and correction of immunological anomalies Curr Pharm Des 2013 19 4893 9 10.2174/1381612811319999032623343120 Search in Google Scholar

[38] Qin H-L, He K-W, Bin G, Ji Y-L, Huang Y-C, Wang S-Q, et al. Human umbilical cord mesenchymal stem cell transplantation combined with angioplasty for diabetic foot: 3 months angiographic evaluation. Zhongguo Zuzhi Gongcheng Yanjiu [Chinese J Tissue Eng Res]. 2013; 17:2544–51. QinH-L HeK-W BinG JiY-L HuangY-C WangS-Q Human umbilical cord mesenchymal stem cell transplantation combined with angioplasty for diabetic foot: 3 months angiographic evaluation Zhongguo Zuzhi Gongcheng Yanjiu [Chinese J Tissue Eng Res] 2013 17 2544 51 Search in Google Scholar

[39] Han S-K, Kim H-R, Kim W-K. The treatment of diabetic foot ulcers with uncultured, processed lipoaspirate cells: a pilot study. Wound Repair Regen. 2010; 18:342–8. HanS-K KimH-R KimW-K The treatment of diabetic foot ulcers with uncultured, processed lipoaspirate cells: a pilot study Wound Repair Regen 2010 18 342 8 10.1111/j.1524-475X.2010.00593.x20492632 Search in Google Scholar

[40] Lee HC, An SG, Lee HW, Park J-S, Cha KS, Hong TJ, et al. Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study. Circ J. 2012; 76:1750–60. LeeHC AnSG LeeHW ParkJ-S ChaKS HongTJ Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study Circ J 2012 76 1750 60 10.1253/circj.CJ-11-113522498564 Search in Google Scholar

[41] Masłowski L, Paprocka M, Czyżewska-Buczyńska A, Bielawska-Pohl A, Duś D, Grendziak R, et al. Autotransplantation of the adipose tissue-derived mesenchymal stem cells in therapy of venous stasis ulcers. Arch Immunol Ther Exp (Warsz). 2020; 68:5. doi: 10.1007/s00005-020-00571-9 MasłowskiL PaprockaM Czyżewska-BuczyńskaA Bielawska-PohlA DuśD GrendziakR Autotransplantation of the adipose tissue-derived mesenchymal stem cells in therapy of venous stasis ulcers Arch Immunol Ther Exp (Warsz) 2020 68 5 10.1007/s00005-020-00571-932060631 Open DOISearch in Google Scholar

[42] Marino G, Moraci M, Armenia E, Orabona C, Sergio R, De Sena G, et al. Therapy with autologous adipose-derived regenerative cells for the care of chronic ulcer of lower limbs in patients with peripheral arterial disease. J Surg Res. 2013; 185:36–44. MarinoG MoraciM ArmeniaE OrabonaC SergioR De SenaG Therapy with autologous adipose-derived regenerative cells for the care of chronic ulcer of lower limbs in patients with peripheral arterial disease J Surg Res 2013 185 36 44 10.1016/j.jss.2013.05.02423773718 Search in Google Scholar

[43] Moon K-C, Suh H-S, Kim K-B, Han S-K, Young K-W, Lee J-W, Kim M-H. Potential of allogeneic adipose-derived stem cell–hydrogel complex for treating diabetic foot ulcers. Diabetes. 2019; 68:837–46. MoonK-C SuhH-S KimK-B HanS-K YoungK-W LeeJ-W KimM-H Potential of allogeneic adipose-derived stem cell–hydrogel complex for treating diabetic foot ulcers Diabetes 2019 68 837 46 10.2337/db18-069930679183 Search in Google Scholar

[44] Viswanathan C, Shetty P, Sarang S, Cooper K, Ghosh D, Bal A. Role of combination cell therapy in non-healing diabetic ulcers in patients with severe peripheral arterial disease – a preliminary report on five cases. J Diabetic Foot Complications. 2013; 5:1–14. ViswanathanC ShettyP SarangS CooperK GhoshD BalA Role of combination cell therapy in non-healing diabetic ulcers in patients with severe peripheral arterial disease – a preliminary report on five cases J Diabetic Foot Complications 2013 5 1 14 Search in Google Scholar

[45] Tanaka R, Masuda H, Kato S, Imagawa K, Kanabuchi K, Nakashioya C, et al. Autologous G-CSF-mobilized peripheral blood CD34⁺ cell therapy for diabetic patients with chronic nonhealing ulcer. Cell Transplant. 2014; 23:167–79. TanakaR MasudaH KatoS ImagawaK KanabuchiK NakashioyaC Autologous G-CSF-mobilized peripheral blood CD34⁺ cell therapy for diabetic patients with chronic nonhealing ulcer Cell Transplant 2014 23 167 79 10.3727/096368912X65800723107450 Search in Google Scholar

[46] Xu SM, Liang T. Clinical observation of the application of autologous peripheral blood stem cell transplantation for the treatment of diabetic foot gangrene. Exp Ther Med. 2016; 11:283–8. XuSM LiangT Clinical observation of the application of autologous peripheral blood stem cell transplantation for the treatment of diabetic foot gangrene Exp Ther Med 2016 11 283 8 10.3892/etm.2015.2888472710026889255 Search in Google Scholar

[47] Stiner R, Alexander M, Liu G, Liao W, Liu Y, Yu J, et al. Transplantation of stem cells from umbilical cord blood as therapy for type I diabetes. Cell Tissue Res. 2019; 378:155–62. StinerR AlexanderM LiuG LiaoW LiuY YuJ Transplantation of stem cells from umbilical cord blood as therapy for type I diabetes Cell Tissue Res 2019 378 155 62 10.1007/s00441-019-03046-231209568 Search in Google Scholar

[48] Lopes L, Setia O, Aurshina A, Liu S, Hu H, Isaji T, et al. Stem cell therapy for diabetic foot ulcers: a review of preclinical and clinical research. Stem Cell Res Ther. 2018; 9:188. doi: 10.1186/s13287-018-0938-6 LopesL SetiaO AurshinaA LiuS HuH IsajiT Stem cell therapy for diabetic foot ulcers: a review of preclinical and clinical research Stem Cell Res Ther 2018 9 188 10.1186/s13287-018-0938-6604225429996912 Open DOISearch in Google Scholar

[49] Abdal Dayem A, Lee SB, Kim K, Lim KM, Jeon T-I, Seok J, Cho S-G. Production of mesenchymal stem cells through stem cell reprogramming. Int J Mol Sci. 2019; 20:1922. doi: 10.3390/ijms20081922 Abdal DayemA LeeSB KimK LimKM JeonT-I SeokJ ChoS-G Production of mesenchymal stem cells through stem cell reprogramming Int J Mol Sci 2019 20 1922 10.3390/ijms20081922651465431003536 Open DOISearch in Google Scholar

[50] Lau T, Lam F, Lau K, Chan Y, Lee K, Sahota D, et al. Pharmacological investigation on the wound healing effects of Radix Rehmanniae in an animal model of diabetic foot ulcer. J Ethnopharmacol. 2009; 123:155–62. LauT LamF LauK ChanY LeeK SahotaD Pharmacological investigation on the wound healing effects of Radix Rehmanniae in an animal model of diabetic foot ulcer J Ethnopharmacol 2009 123 155 62 10.1016/j.jep.2009.02.01019429355 Search in Google Scholar

[51] Watt SM, Gullo F, van der Garde M, Markeson D, Camicia R, Khoo CP, Zwaginga JJ. The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential. Br Med Bull. 2013; 108:25–53. WattSM GulloF van der GardeM MarkesonD CamiciaR KhooCP ZwagingaJJ The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential Br Med Bull 2013 108 25 53 10.1093/bmb/ldt031384287524152971 Search in Google Scholar

[52] Zhao Q-S, Xia N, Zhao N, Li M, Bi C-L, Zhu Q, et al. Localization of human mesenchymal stem cells from umbilical cord blood and their role in repair of diabetic foot ulcers in rats. Int J Biol Sci. 2014; 10:80–9. ZhaoQ-S XiaN ZhaoN LiM BiC-L ZhuQ Localization of human mesenchymal stem cells from umbilical cord blood and their role in repair of diabetic foot ulcers in rats Int J Biol Sci 2014 10 80 9 10.7150/ijbs.7237387959424391454 Search in Google Scholar

[53] Zhou N, Wang Q-P, Jin X-F, Hou Z-L, Peng B-K, Dan Q-Q, Wang T-H. [Effect of human umbilici mesenchymal stromal cells implantation on the BDNF expression in diabetic foot rats]. Sichuan Da Xue Xue Bao Yi Xue Ban [J Sichuan Univ. Med Sci Edition]. 2013; 44:931–4. [article in Chinese, English Abstract] ZhouN WangQ-P JinX-F HouZ-L PengB-K DanQ-Q WangT-H [Effect of human umbilici mesenchymal stromal cells implantation on the BDNF expression in diabetic foot rats] Sichuan Da Xue Xue Bao Yi Xue Ban [J Sichuan Univ. Med Sci Edition] 2013 44 931 4 [article in Chinese, English Abstract] Search in Google Scholar

[54] You H-J, Namgoong S, Han S-K, Jeong S-H, Dhong E-S, Kim W-K. Wound-healing potential of human umbilical cord blood–derived mesenchymal stromal cells in vitro—a pilot study. Cytotherapy. 2015; 17:1506–13. YouH-J NamgoongS HanS-K JeongS-H DhongE-S KimW-K Wound-healing potential of human umbilical cord blood–derived mesenchymal stromal cells in vitro—a pilot study Cytotherapy 2015 17 1506 13 10.1016/j.jcyt.2015.06.01126212609 Search in Google Scholar

[55] Qin H-L, He K-W, Gao B, Ji Y-L, Huang Y-C, Wang S-Q, et al. Human umbilical cord mesenchymal stem cell transplantation combined with angioplasty for diabetic foot: 3 months angiographic evaluation. Chinese J Tissue Eng Res. 2013; 17:2544–51. QinH-L HeK-W GaoB JiY-L HuangY-C WangS-Q Human umbilical cord mesenchymal stem cell transplantation combined with angioplasty for diabetic foot: 3 months angiographic evaluation Chinese J Tissue Eng Res 2013 17 2544 51 Search in Google Scholar

[56] Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002; 13:4279–95. ZukPA ZhuM AshjianP De UgarteDA HuangJI MizunoH Human adipose tissue is a source of multipotent stem cells Mol Biol Cell 2002 13 4279 95 10.1091/mbc.e02-02-010513863312475952 Search in Google Scholar

[57] Wu Q, Chen B, Liang Z. Mesenchymal stem cells as a prospective therapy for the diabetic foot. Stem Cells Int. 2016; 2016:4612167. doi: 10.1155/2016/4612167 WuQ ChenB LiangZ Mesenchymal stem cells as a prospective therapy for the diabetic foot Stem Cells Int 2016 2016 4612167. 10.1155/2016/4612167510275027867398 Open DOISearch in Google Scholar

[58] Nambu M, Ishihara M, Kishimoto S, Yanagibayashi S, Yamamoto N, Azuma R, et al. Stimulatory effect of autologous adipose tissue-derived stromal cells in an atelocollagen matrix on wound healing in diabetic db/db mice. J Tissue Eng. 2011; 2011:158105. doi: 10.4061/2011/158105 NambuM IshiharaM KishimotoS YanagibayashiS YamamotoN AzumaR Stimulatory effect of autologous adipose tissue-derived stromal cells in an atelocollagen matrix on wound healing in diabetic db/db mice J Tissue Eng 2011 2011 158105 10.4061/2011/158105313605921772956 Open DOISearch in Google Scholar

[59] Yang M, Sheng L, Zhang TR, Li Q. Stem cell therapy for lower extremity diabetic ulcers: where do we stand? Biomed Res Int. 2013; 2013:462179. doi: 10.1155/2013/462179 YangM ShengL ZhangTR LiQ Stem cell therapy for lower extremity diabetic ulcers: where do we stand? Biomed Res Int 2013 2013 462179. 10.1155/2013/462179361308523586040 Open DOISearch in Google Scholar

[60] Hassan WU, Greiser U, Wang W. Role of adipose-derived stem cells in wound healing. Wound Repair Regen. 2014; 22:313–25. HassanWU GreiserU WangW Role of adipose-derived stem cells in wound healing Wound Repair Regen 2014 22 313 25 10.1111/wrr.1217324844331 Search in Google Scholar

[61] Kim YJ, Kim HK, Cho HH, Bae YC, Suh KT, Jung JS. Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cell Physiol Biochem. 2007; 20:867–76. KimYJ KimHK ChoHH BaeYC SuhKT JungJS Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia Cell Physiol Biochem 2007 20 867 76 10.1159/00011044717982269 Search in Google Scholar

[62] Ikegame Y, Yamashita K, Hayashi S-I, Mizuno H, Tawada M, You F, et al. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy. 2011; 13:675–85. IkegameY YamashitaK HayashiS-I MizunoH TawadaM YouF Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy Cytotherapy 2011 13 675 85 10.3109/14653249.2010.54912221231804 Search in Google Scholar

[63] Jiang X-Y, Lu D-B, Chen B. Progress in stem cell therapy for the diabetic foot. Diabetes Res Clin Pract. 2012; 97:43–50. JiangX-Y LuD-B ChenB Progress in stem cell therapy for the diabetic foot Diabetes Res Clin Pract 2012 97 43 50 10.1016/j.diabres.2011.12.01122221581 Search in Google Scholar

[64] Kim S-W, Zhang H-Z, Guo L, Kim J-M, Kim MH. Amniotic mesenchymal stem cells enhance wound healing in diabetic NOD/SCID mice through high angiogenic and engraftment capabilities. PLoS One. 2012; 7:e41105. doi: 10.1371/journal.pone.0041105 KimS-W ZhangH-Z GuoL KimJ-M KimMH Amniotic mesenchymal stem cells enhance wound healing in diabetic NOD/SCID mice through high angiogenic and engraftment capabilities PLoS One 2012 7 e41105 10.1371/journal.pone.0041105339888922815931 Open DOISearch in Google Scholar

[65] Bura A, Planat-Benard V, Bourin P, Silvestre J-S, Gross F, Grolleau J-L, et al. Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia. Cytotherapy. 2014; 16:245–57. BuraA Planat-BenardV BourinP SilvestreJ-S GrossF GrolleauJ-L Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia Cytotherapy 2014 16 245 57 10.1016/j.jcyt.2013.11.01124438903 Search in Google Scholar

[66] Kato Y, Iwata T, Washio K, Yoshida T, Kuroda H, Morikawa S, et al. Creation and transplantation of an adipose-derived stem cell (ASC) sheet in a diabetic wound-healing model. J Vis Exp. 2017:e54539. doi: 10.3791/54539 KatoY IwataT WashioK YoshidaT KurodaH MorikawaS Creation and transplantation of an adipose-derived stem cell (ASC) sheet in a diabetic wound-healing model J Vis Exp 2017 e54539 10.3791/54539561401528809824 Open DOISearch in Google Scholar

[67] Shingyochi Y, Orbay H, Mizuno H. Adipose-derived stem cells for wound repair and regeneration. Expert Opin Biol Ther. 2015; 15:1285–92. ShingyochiY OrbayH MizunoH Adipose-derived stem cells for wound repair and regeneration Expert Opin Biol Ther 2015 15 1285 92 10.1517/14712598.2015.105386726037027 Search in Google Scholar

[68] Ito K, Bonora M, Ito K. Metabolism as master of hematopoietic stem cell fate. Int J Hematol. 2019; 109:18–27. ItoK BonoraM ItoK Metabolism as master of hematopoietic stem cell fate Int J Hematol 2019 109 18 27 10.1007/s12185-018-2534-z631806430219988 Search in Google Scholar

[69] Huo Y, Li B-Y, Lin Z-F, Wang W, Jiang X-X, Chen X, et al. MYSM1 is essential for maintaining hematopoietic stem cell (HSC) quiescence and survival. Med Sci Monit. 2018; 24:2541–9. HuoY LiB-Y LinZ-F WangW JiangX-X ChenX MYSM1 is essential for maintaining hematopoietic stem cell (HSC) quiescence and survival Med Sci Monit 2018 24 2541 9 10.12659/MSM.906876593994829694335 Search in Google Scholar

[70] Haspel RL, Miller KB. Hematopoietic stem cells: source matters. Curr Stem Cell Res Ther. 2008; 3:229–36. HaspelRL MillerKB Hematopoietic stem cells: source matters Curr Stem Cell Res Ther 2008 3 229 36 10.2174/15748880878673403319075753 Search in Google Scholar

[71] Seita J, Weissman IL. Hematopoietic stem cell: self-renewal versus differentiation. Wiley Interdiscip Rev Syst Biol Med. 2010; 2:640–53. SeitaJ WeissmanIL Hematopoietic stem cell: self-renewal versus differentiation Wiley Interdiscip Rev Syst Biol Med 2010 2 640 53 10.1002/wsbm.86295032320890962 Search in Google Scholar

[72] Hossle JP, Seger RA, Steinhoff D. Gene therapy of hematopoietic stem cells: strategies for improvement. News Physiol Sci. 2002; 17:87–92. HossleJP SegerRA SteinhoffD Gene therapy of hematopoietic stem cells: strategies for improvement News Physiol Sci 2002 17 87 92 Search in Google Scholar

[73] Kanji S, Das M, Aggarwal R, Lu J, Joseph M, Pompili VJ, Das H. Nanofiber-expanded human umbilical cord blood–derived CD 34⁺ cell therapy accelerates cutaneous wound closure in NOD/SCID mice. J Cell Mol Med. 2014; 18:685–97. KanjiS DasM AggarwalR LuJ JosephM PompiliVJ DasH Nanofiber-expanded human umbilical cord blood–derived CD 34⁺ cell therapy accelerates cutaneous wound closure in NOD/SCID mice J Cell Mol Med 2014 18 685 97 10.1111/jcmm.12217398193924455991 Search in Google Scholar

[74] Körbling M, Katz RL, Khanna A, Ruifrok AC, Rondon G, Albitar M, et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med. 2002; 346:738–46. KörblingM KatzRL KhannaA RuifrokAC RondonG AlbitarM Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells N Engl J Med 2002 346 738 46 10.1056/NEJMoa346100211882729 Search in Google Scholar

[75] Kirby GTS, Mills SJ, Cowin AJ, Smith LE. Stem cells for cutaneous wound healing. Biomed Res Int. 2015; 2015:285869. doi: 10.1155/2015/285869 KirbyGTS MillsSJ CowinAJ SmithLE Stem cells for cutaneous wound healing Biomed Res Int 2015 2015 285869 10.1155/2015/285869446827626137471 Open DOISearch in Google Scholar

[76] Sietsema WK, Kawamoto A, Takagi H, Losordo DW. Autologous CD34⁺ cell therapy for ischemic tissue repair. Circ J. 2019; 83:1422–30. SietsemaWK KawamotoA TakagiH LosordoDW Autologous CD34⁺ cell therapy for ischemic tissue repair Circ J 2019 83 1422 30 10.1253/circj.CJ-19-024031178469 Search in Google Scholar

[77] Barcelos LS, Duplaa C, Kränkel N, Graiani G, Invernici G, Katare R, et al. Human CD133⁺ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res. 2009; 104:1095–102. BarcelosLS DuplaaC KränkelN GraianiG InverniciG KatareR Human CD133⁺ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling Circ Res 2009 104 1095 102 10.1161/CIRCRESAHA.108.192138282101419342601 Search in Google Scholar

[78] Chotinantakul K, Dechsukhum C, Dejjuy D, Leeanansaksiri W. Enhancement of wound closure in diabetic mice by ex vivo expanded cord blood CD34⁺ cells. Cell Mol Biol Lett. 2013; 18:263–83. ChotinantakulK DechsukhumC DejjuyD LeeanansaksiriW Enhancement of wound closure in diabetic mice by ex vivo expanded cord blood CD34⁺ cells Cell Mol Biol Lett 2013 18 263 83 10.2478/s11658-013-0089-9627598223666595 Search in Google Scholar

[79] Lewis P, Silajdžić E, Brison DR, Kimber SJ. Embryonic stem cells. In: Gimble JM, Marolt Preson D, Oreffo R, Wolbank S, Redl H, editors. Cell engineering and regeneration. Redl H, series editor. Reference Series in Biomedical Engineering. Cham: Springer Nature Switzerland; 2020, p. 315–65. LewisP SilajdžićE BrisonDR KimberSJ Embryonic stem cells In: GimbleJM Marolt PresonD OreffoR WolbankS RedlH editors. Cell engineering and regeneration RedlH series editor. Reference Series in Biomedical Engineering Cham Springer Nature Switzerland 2020 315 65 10.1007/978-3-319-08831-0_19 Search in Google Scholar

[80] Lee KB, Choi J, Cho S-B, Chung J-Y, Moon E-S, Kim N-S, Han H-J. Topical embryonic stem cells enhance wound healing in diabetic rats. J Orthop Res. 2011; 29:1554–62. LeeKB ChoiJ ChoS-B ChungJ-Y MoonE-S KimN-S HanH-J Topical embryonic stem cells enhance wound healing in diabetic rats J Orthop Res 2011 29 1554 62 10.1002/jor.2138521469178 Search in Google Scholar

[81] Loretelli C, Nasr MB, Giatsidis G, Bassi R, Lancerotto L, D’Addio F, et al. Embryonic stem cell extracts improve wound healing in diabetic mice. Acta Diabetol. 2020: 57:883–90. LoretelliC NasrMB GiatsidisG BassiR LancerottoL D’AddioF Embryonic stem cell extracts improve wound healing in diabetic mice Acta Diabetol 2020 57 883 90 10.1007/s00592-020-01500-032124076 Search in Google Scholar

[82] Lee MJ, Kim J, Lee KI, Shin JM, Chae JI, Chung HM. Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells. Cytotherapy. 2011; 13:165–78. LeeMJ KimJ LeeKI ShinJM ChaeJI ChungHM Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells Cytotherapy 2011 13 165 78 10.3109/14653249.2010.51263221235296 Search in Google Scholar

[83] Clark RAF, Lanigan JM, DellaPelle P, Manseau E, Dvorak HF, Colvin RB. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol. 1982; 79:264–9. ClarkRAF LaniganJM DellaPelleP ManseauE DvorakHF ColvinRB Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization J Invest Dermatol 1982 79 264 9 10.1111/1523-1747.ep125000756752288 Search in Google Scholar

[84] Mohib K, Allan D, Wang L. Human embryonic stem cell-extracts inhibit the differentiation and function of monocyte-derived dendritic cells. Stem Cell Rev Rep. 2010; 6:611–21. MohibK AllanD WangL Human embryonic stem cell-extracts inhibit the differentiation and function of monocyte-derived dendritic cells Stem Cell Rev Rep 2010 6 611 21 10.1007/s12015-010-9185-720711689 Search in Google Scholar

[85] Gorecka J, Kostiuk V, Fereydooni A, Gonzalez L, Luo J, Dash B, et al. The potential and limitations of induced pluripotent stem cells to achieve wound healing. Stem Cell Res Ther. 2019; 10:87. doi: 10.1186/s13287-019-1185-1 GoreckaJ KostiukV FereydooniA GonzalezL LuoJ DashB The potential and limitations of induced pluripotent stem cells to achieve wound healing Stem Cell Res Ther 2019 10 87 10.1186/s13287-019-1185-1641697330867069 Open DOISearch in Google Scholar

[86] Bian X, Ma K, Zhang C, Fu X. Therapeutic angiogenesis using stem cell-derived extracellular vesicles: an emerging approach for treatment of ischemic diseases. Stem Cell Res Ther. 2019; 10:158. doi: 10.1186/s13287-019-1276-z BianX MaK ZhangC FuX Therapeutic angiogenesis using stem cell-derived extracellular vesicles: an emerging approach for treatment of ischemic diseases Stem Cell Res Ther 2019 10 158 10.1186/s13287-019-1276-z654572131159859 Open DOISearch in Google Scholar

[87] Yoshida Y, Yamanaka S. Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell–based regeneration. Circulation. 2010; 122:80–7. YoshidaY YamanakaS Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell–based regeneration Circulation 2010 122 80 7 10.1161/CIRCULATIONAHA.109.88143320606130 Search in Google Scholar

[88] Singh VK, Kalsan M, Kumar N, Saini A, Chandra R. Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery. Front Cell Dev Biol. 2015; 3:2. doi: 10.3389/fcell.2015.00002 SinghVK KalsanM KumarN SainiA ChandraR Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery Front Cell Dev Biol 2015 3 2 10.3389/fcell.2015.00002431377925699255 Open DOISearch in Google Scholar

[89] Baraniak PR, McDevitt TC. Stem cell paracrine actions and tissue regeneration. Regen Med. 2010; 5:121–43. BaraniakPR McDevittTC Stem cell paracrine actions and tissue regeneration Regen Med 2010 5 121 43 10.2217/rme.09.74283327320017699 Search in Google Scholar

[90] Clayton ZE, Tan RP, Miravet MM, Lennartsson K, Cooke JP, Bursill CA, et al. Induced pluripotent stem cell-derived endothelial cells promote angiogenesis and accelerate wound closure in a murine excisional wound healing model. Biosci Rep. 2018; 38:BSR20180563. doi: 10.1042/BSR20180563 ClaytonZE TanRP MiravetMM LennartssonK CookeJP BursillCA Induced pluripotent stem cell-derived endothelial cells promote angiogenesis and accelerate wound closure in a murine excisional wound healing model Biosci Rep 2018 38 BSR20180563. 10.1042/BSR20180563606665729976773 Open DOISearch in Google Scholar

[91] Itoh M, Umegaki-Arao N, Guo Z, Liu L, Higgins CA, Christiano AM. Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). PLoS One. 2013; 8:e77673. doi: 10.1371/journal.pone.0077673 ItohM Umegaki-AraoN GuoZ LiuL HigginsCA ChristianoAM Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs) PLoS One 2013 8 e77673 10.1371/journal.pone.0077673379568224147053 Open DOISearch in Google Scholar

[92] Gerami-Naini B, Smith A, Maione AG, Kashpur O, Carpinito G, Veves A, et al. Generation of induced pluripotent stem cells from diabetic foot ulcer fibroblasts using a nonintegrative Sendai virus. Cell Reprogram. 2016; 18:214–23. Gerami-NainiB SmithA MaioneAG KashpurO CarpinitoG VevesA Generation of induced pluripotent stem cells from diabetic foot ulcer fibroblasts using a nonintegrative Sendai virus Cell Reprogram 2016 18 214 23 10.1089/cell.2015.0087496476027328415 Search in Google Scholar

[93] Zheng Y, Ji S, Wu H, Tian S, Zhang Y, Wang L, et al. Topical administration of cryopreserved living micronized amnion accelerates wound healing in diabetic mice by modulating local microenvironment. Biomaterials. 2017; 113:56–67. ZhengY JiS WuH TianS ZhangY WangL Topical administration of cryopreserved living micronized amnion accelerates wound healing in diabetic mice by modulating local microenvironment Biomaterials 2017 113 56 67 10.1016/j.biomaterials.2016.10.03127810642 Search in Google Scholar

[94] Lv Y, Ge L, Zhao Y. Effect and mechanism of SHED on ulcer wound healing in Sprague-Dawley rat models with diabetic ulcer. Am J Transl Res. 2017; 9:489–98. LvY GeL ZhaoY Effect and mechanism of SHED on ulcer wound healing in Sprague-Dawley rat models with diabetic ulcer Am J Transl Res 2017 9 489 98 Search in Google Scholar

[95] Badillo AT, Redden RA, Zhang L, Doolin EJ, Liechty KW. Treatment of diabetic wounds with fetal murine mesenchymal stromal cells enhances wound closure. Cell Tissue Res. 2007; 329:301–11. BadilloAT ReddenRA ZhangL DoolinEJ LiechtyKW Treatment of diabetic wounds with fetal murine mesenchymal stromal cells enhances wound closure Cell Tissue Res 2007 329 301 11 10.1007/s00441-007-0417-317453245 Search in Google Scholar

[96] da Silva LP, Santos TC, Rodrigues DB, Pirraco RP, Cerqueira MT, Reis RL, et al. Stem cell-containing hyaluronic acid-based spongy hydrogels for integrated diabetic wound healing. J Invest Dermatol. 2017; 137:1541–51. da SilvaLP SantosTC RodriguesDB PirracoRP CerqueiraMT ReisRL Stem cell-containing hyaluronic acid-based spongy hydrogels for integrated diabetic wound healing J Invest Dermatol 2017 137 1541 51 10.1016/j.jid.2017.02.97628259681 Search in Google Scholar

[97] Kwon DS, Gao X, Liu YB, Dulchavsky DS, Danyluk AL, Bansal M, et al. Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats. Int Wound J. 2008; 5:453–63. KwonDS GaoX LiuYB DulchavskyDS DanylukAL BansalM Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats Int Wound J 2008 5 453 63 10.1111/j.1742-481X.2007.00408.x385290718593394 Search in Google Scholar

[98] Ho JH, Tseng T-C, Ma W-H, Ong W-K, Chen Y-F, Chen M-H, et al. Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and β-cell differentiation in streptozocin-induced diabetic mice. Cell Transplant. 2012; 21:997–1009. HoJH TsengT-C MaW-H OngW-K ChenY-F ChenM-H Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and β-cell differentiation in streptozocin-induced diabetic mice Cell Transplant 2012 21 997 1009 10.3727/096368911X60361122004871 Search in Google Scholar

[99] Acosta L, Hmadcha A, Escacena N, Pérez-Camacho I, de la Cuesta A, Ruiz-Salmeron R, et al. Adipose mesenchymal stromal cells isolated from type 2 diabetic patients display reduced fibrinolytic activity. Diabetes. 2013: 62:4266–9. AcostaL HmadchaA EscacenaN Pérez-CamachoI de la CuestaA Ruiz-SalmeronR Adipose mesenchymal stromal cells isolated from type 2 diabetic patients display reduced fibrinolytic activity Diabetes 2013 62 4266 9 10.2337/db13-0896383706124043757 Search in Google Scholar

[100] Wang Y, Han Z-B, Song Y-P, Han ZC. Safety of mesenchymal stem cells for clinical application. Stem Cells Int. 2012; 2012:652034. doi: 10.1155/2012/652034 WangY HanZ-B SongY-P HanZC Safety of mesenchymal stem cells for clinical application Stem Cells Int 2012 2012 652034 10.1155/2012/652034336328222685475 Open DOISearch in Google Scholar

[101] Rubio D, Garcia-Castro J, Martín MC, de la Fuente R, Cigudosa JC, Lloyd AC, et al. Spontaneous human adult stem cell transformation. Cancer Res. 2005; 65:3035–9. RubioD Garcia-CastroJ MartínMC de la FuenteR CigudosaJC LloydAC Spontaneous human adult stem cell transformation Cancer Res 2005 65 3035 9 10.1158/0008-5472.CAN-04-419415833829 Search in Google Scholar

[102] de la Fuente R, Bernad A, Garcia-Castro J, Martín MC, Cigudosa JC. Retraction: Spontaneous human adult stem cell transformation. Cancer Res. 2010; 70:6682. de la FuenteR BernadA Garcia-CastroJ MartínMC CigudosaJC Retraction: Spontaneous human adult stem cell transformation Cancer Res 2010 70 6682 10.1158/0008-5472.CAN-10-245120710046 Search in Google Scholar

[103] Yang S-S, Kim N-R, Park K-B, Do Y-S, Roh K, Kang K-S, et al. A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease. Int. J Stem Cells. 2013; 6:37–44. YangS-S KimN-R ParkK-B DoY-S RohK KangK-S A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease Int. J Stem Cells 2013 6 37 44 10.15283/ijsc.2013.6.1.37384100224298372 Search in Google Scholar

[104] Qi L, Ahmadi AR, Huang J, Chen M, Pan B, Kuwabara H, et al. Major improvement in wound healing through pharmacologic mobilization of stem cells in severely diabetic rats. Diabetes. 2020; 69:699–712. QiL AhmadiAR HuangJ ChenM PanB KuwabaraH Major improvement in wound healing through pharmacologic mobilization of stem cells in severely diabetic rats Diabetes 2020 69 699 712 10.2337/db19-090731974141 Search in Google Scholar